Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EG&G/PE Corp.

This article was originally published in The Gray Sheet

Executive Summary

EG&G completes $425 mil. acquisition of PE's Analytical Instruments business and gains rights to the "Perkin-Elmer" brand name, PE Corp. reports June 1. Announced March 8, the deal consists of $275 mil. in cash and $150 mil. in EG&G debt bearing a 5% coupon having a one-year maturity ("The Gray Sheet" March 15, p. 4)

You may also be interested in...

PerkinElmer's $400 Mil. NEN Buy Highlights Build In Genomics M&A Activity

Acquisition of NEN Life Sciences from the private equity investment firm Genstar Capital LLC for approximately $400 mil. will expand PerkinElmer's life sciences business and broaden the company's functional genomics and high-throughput screening offerings.

Former MiMedX Execs Convicted On Securities Fraud Charges

The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts